Shilajit Side Effects: What You Need to Know
In short: Purified or processed Shilajit has generally been well tolerated in the relatively small human studies conducted so far, at the specific doses, preparations and durations investigated. Some studies have monitored liver, kidney, blood and other safety markers without identifying major concerns. However, the clinical safety database remains limited, and the available research does not prove that Shilajit is completely safe for everyone, safe in every formulation or safe for unrestricted long-term daily use.
Important: Gold+ is a UK food supplement, not a medicine. If you take prescription medication or have a significant health condition, speak to a pharmacist or GP before use. If you develop a new unwanted symptom after starting Shilajit, stop and reassess rather than continuing.
Three safety questions worth separating
Most Shilajit safety content blurs three very different questions together. Keeping them separate makes the answers more useful.
1. What do human studies of purified or processed Shilajit tell us? This is where we discuss clinical tolerability, measured safety markers and reported adverse events from actual human research.
2. What do we know about the actual product? A study using one standardised preparation cannot automatically be applied to every Shilajit product sold online. Source, preparation and finished-product testing all matter independently.
3. Is Shilajit appropriate for this particular person? This includes medicines, health conditions, pregnancy, breastfeeding, age, allergies and previous reactions.
A reassuring human study does not prove that every Shilajit product is safe. A clean laboratory report does not prove that an individual cannot experience an unwanted reaction. And neither proves that Shilajit is suitable for everyone.
"Safe" should never mean "nothing could possibly happen." Good safety communication means explaining what we know, what remains uncertain, how product quality changes the risk and when an individual should decide not to take something.
A note from the founder
The thing that concerned me most when I started researching Shilajit was not the side-effect profile of purified preparations. It was the quality variability of what was actually being sold.
Shilajit is a complex natural material that originates in geological environments. It is not a clean, standardised ingredient by default. The Ayurvedic tradition understood this — Shodhana, the classical purification process, was not an optional refinement. It was considered essential before Shilajit could be used therapeutically. The classical texts were explicit that unpurified Shilajit was not appropriate for use. That is not a modern safety concern invented by supplement brands. It is a principle that has been part of the Ayurvedic framework for centuries.
More recent analytical research has confirmed why that matters. Studies published in 2025 and 2026 examining Shilajit samples from different geographical origins found substantial variation in elemental profiles, including the presence of potentially toxic elements. One study specifically investigating thallium found it in both natural Shilajit and some commercial products. These are not theoretical concerns. They are measurable findings from independent laboratory analysis.
My own experience with Shilajit has been straightforward. I have not experienced the dramatic detox reactions that some online content describes. I did not feel an immediate stimulant effect. I judged it over time, as part of a wider routine, and I think that is the right way to approach it.
If someone experiences a new unwanted symptom after starting Shilajit, I do not think the right response is to push through it on the assumption that it is a detox reaction. That narrative — that feeling worse initially means the product is working — is not supported by the human clinical research. The studies that have monitored safety markers have not described a detox phase as a normal or expected part of the process.
Gold+ was built around the principle that testing reduces uncertainty. It does not eliminate it. Independent Eurofins testing tells you something meaningful about the composition and contaminant profile of the finished product. It does not guarantee that every individual will tolerate it well, or that no unwanted effect is possible. That is an honest position, and it is the one we stand behind.
What human studies actually tell us
The human Shilajit safety evidence comes primarily from a small number of clinical studies, each using specific preparations at specific doses over defined periods. The findings are generally reassuring — but they apply to those preparations, those doses and those populations.
The 90-day testosterone trial. A randomised, double-blind, placebo-controlled study in healthy men aged 45–55 used purified Shilajit at 250 mg twice daily for 90 days. No significant adverse events were reported. [1]
The oligospermia fertility study. A clinical study in 35 men with oligospermia used processed Shilajit at 100 mg twice daily for 90 days. Among the 28 completers, hepatic and renal function profiles were reported as unaltered. No significant adverse events were described. [2]
The eight-week performance study. A randomised study in 63 recreationally active men used purified Shilajit at 250 mg/day or 500 mg/day for eight weeks. No significant safety concerns were reported at either dose. [3]
The 48-week postmenopausal bone trial. A randomised, double-blind, placebo-controlled trial in 60 postmenopausal women with osteopenia used a standardised aqueous Shilajit extract at 250 mg/day or 500 mg/day for 48 weeks. Oxidative-stress markers and inflammatory markers were monitored alongside bone outcomes. No significant adverse events were reported. [4]
The 14-week skin study. A randomised study in 45 middle-aged women used Shilajit at 125 mg or 250 mg twice daily for 14 weeks. No significant safety concerns were reported. [5]
What this evidence does not establish: that every Shilajit product is safe, that higher doses are safe, that indefinite long-term use is safe, or that individuals with health conditions or on medication will tolerate Shilajit without issue. The studies used defined preparations in relatively healthy populations over defined periods.
What side effects have actually been reported?
The human clinical studies have not identified a consistent pattern of serious adverse effects at the studied doses and preparations. That is a meaningful finding. It is not the same as proving Shilajit is free of all possible side effects for all people.
Outside of controlled trials, the following have been reported anecdotally or in case reports and should be acknowledged honestly:
| Reported effect | What it likely means | What to do |
|---|---|---|
| Digestive discomfort, nausea or loose stools | Often related to taking on an empty stomach or individual sensitivity | Take with food; if it persists, stop and reassess |
| Headache | Individual response; not consistently reported in trials | Stop and reassess; do not continue through persistent headache |
| Increased heart rate or palpitations | Not a documented effect of purified Shilajit in trials; may reflect individual sensitivity or product quality | Stop immediately; seek medical advice if it persists |
| Dizziness | Individual response; not consistently reported in trials | Stop and reassess |
| Sleep disruption or vivid dreams | Anecdotally reported; more likely with evening use | Switch to morning use with food; if it persists, stop |
| Allergic reaction (rash, itching, swelling) | Possible with any supplement; individual hypersensitivity | Stop immediately; seek medical advice |
| No noticeable effect | Common; Shilajit is not a stimulant and does not produce an immediate perceptible response in most people | This is not a sign the product is not working; judge over weeks, not days |
The "detox reaction" narrative. Some Shilajit content describes initial unwanted symptoms — headache, fatigue, digestive upset — as a "detox reaction" proving the product is working. The human clinical studies that have monitored safety markers have not described a detox phase as a normal or expected part of the process. If you experience new unwanted symptoms after starting Shilajit, stop and reassess rather than continuing on the assumption that feeling worse means the product is working.
Contamination, quality and what testing establishes
The most significant safety variable for Shilajit is not the side-effect profile of purified preparations — it is the quality of the product being used.
Shilajit originates as a complex natural material associated with geological environments. Naturally occurring and introduced contaminants are legitimate quality-control considerations. Recent analytical research examining Shilajit samples from different geographical origins found substantial variation in elemental profiles, including the presence of potentially toxic elements. [6] A 2025 study specifically investigating thallium found it in both natural Shilajit and some commercial products. [7]
Appropriate, controlled purification is a positive quality step, not evidence that something has been ruined. The Ayurvedic tradition recognised this — Shodhana, the classical purification process, was considered essential before therapeutic use, not optional.
What independent testing can and cannot tell you
- Can tell you: measured contaminant concentrations in the tested batch; measured fulvic-acid composition; microbial safety of the tested batch
- Cannot tell you: that every batch will be identical; that the product is safe for every individual; that no unwanted effect is possible; that the product will produce the same outcomes as the preparations used in clinical research
Gold+ Capsules and Resin have been independently tested by Eurofins for fulvic-acid content (79.22% and 76.74% respectively), heavy metals (arsenic, cadmium, lead, mercury) and microbial safety. Those results are available on request. Testing reduces uncertainty. It does not eliminate it.
Who should avoid Shilajit or seek advice first?
Do not use Shilajit Gold+ if you are pregnant or breastfeeding. There is insufficient Shilajit-specific human research to establish safety during pregnancy or breastfeeding. This is a precaution based on insufficient evidence, not proof of harm.
Is Shilajit Gold+ Right for You?
| Your situation | What to do |
|---|---|
| Pregnant or breastfeeding | Do not use. Insufficient safety evidence. |
| Taking prescription medication | Check first. Speak to your GP or pharmacist before use. |
| Kidney or liver disease | Check first. Speak to your GP before use. |
| Gout or haemochromatosis | Check first. Pharmacologically plausible risk — discuss with your GP. |
| Organ transplant / immunosuppressants | Check first. Speak to your specialist team. |
| Under 18 | Not recommended. No safety data in this age group. |
| Healthy adult, no medication, no relevant conditions | Generally suitable. Take with food, morning use, labelled serving only. |
This is a general guide only. If in doubt, speak to a pharmacist or GP before use.
Gout — specific note: Shilajit contains purines. In individuals with gout or hyperuricaemia, purine intake can raise uric acid levels and may trigger or worsen a gout flare. This is not a theoretical concern — it is a pharmacologically plausible mechanism in a susceptible population. If you have gout or a history of gout, discuss Shilajit with your GP before use.
Haemochromatosis and kidney transplant — specific note: Shilajit may influence iron metabolism, which is a relevant consideration for individuals with haemochromatosis or other iron-overload conditions. For kidney transplant recipients on immunosuppressant medication, the interaction profile of Shilajit with those drugs has not been well established. In both cases, discuss with your specialist before use.
Does Shilajit interact with medication?
Direct human pharmacokinetic interaction studies between Shilajit and specific medications are limited. The absence of a well-documented interaction does not mean an interaction has been proven safe — it often means the combination has not been adequately studied.
The following medication groups warrant particular caution and a conversation with a pharmacist, GP or specialist before combining with Shilajit: